NPC2 · Western blot design guide

NPC2 Western Blot Planning Guide

Plan a NPC2 Western blot around the catalog-observed 16.6 kDa band, image-backed A01582-2 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for NPC2 (NPC2): expected band 16.6 kDa, antibody A01582-2, and guide-derived SDS-PAGE protocol steps
NPC2 Western blot protocol sheet — expected band 16.6 kDa, antibody A01582-2, controls and PMC citations. Open the full NPC2 WB guide →

NPC2 Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 16.6 kDa
Observed band Not reported — verify product WB image
Gel 15%
Positive control ⓘ Lung
Negative control ⓘ Cerebral cortex
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 16.6 kDa
ⓘ Localization Secreted / Endoplasmic reticulum
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human / Mouse
Section 1

Real Curated NPC2 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateEpididymis
Gel %15%
Load20-30 µg total protein per lane
TransferSemi-dry, short transfer
Membrane0.2 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA01582-2 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected NPC2 Western Blot Band Size?

Use the product-observed 16.6 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
16.6 kDaMatches the authoritative product WB observation.
16.6 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected NPC2 appearancePlan around 16.6 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band16.6 kDa; use this as the primary experimental expectation.
Calculated mass16.6 kDa from UniProt P61916; retain as context.
Gel selection15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A01582-2.
Why is my band missing or off?
SituationLikely causeNext action
16.6 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for NPC2 Western blot

🧪Use Lung as the first positive-control candidate and Cerebral cortex as the HPA Not detected negative candidate.
Positive control: Lung (High)
Negative control: Cerebral cortex (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for NPC2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Lung Reported tissue cells High Protein (HPA) HPA →
Testis Reported tissue cells High Protein (HPA) HPA →
Kidney Reported tissue cells High Protein (HPA) HPA →
Epididymis Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Cerebral cortex Reported tissue cells Not detected Protein (HPA) HPA →
Cerebellum Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced NPC2 Western Blot Tips

Deeper troubleshooting and optimisation questions for NPC2, answered from its protein features.

Which band should guide the blot?
Use 16.6 kDa, the observation attached to the authoritative A01582-2 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 16.6 kDa expectation.
Which positive control should I start with?
Start with Lung, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Cerebral cortex as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for NPC2 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A01582-2 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

NPC2 Western Blot Reagents

Human/Mouse-reactive NPC2 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for NPC2 using A01582-2; observed band 16.6 kDa
Anti-Niemann Pick C2/NPC2 Antibody Picoband®
Cat # A01582-2
Real WB data Western blot validation image for NPC2 using A01582-3; observed band 16.6 kDa
Anti-Niemann Pick C2/NPC2 Picoband® Antibody
Cat # A01582-3

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt P61916
  2. Human Protein Atlas — NPC2
  3. A01582-2 product record
  4. PMC12274260 — ALKBH5-mediated NPC2 mRNA m(6)A demethylation promotes resistance to oxaliplatin in colorectal cancer (Functional & integrative genomics, 2025)
  5. PMC6032364 — Niemann-Pick Type C2 Protein Regulates Free Cholesterol Accumulation and Influences Hepatic Stellate Cell Proliferation and Mitochondrial Respiration Function (International journal of molecular sciences, 2018)
  6. PMC4964497 — Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation (International journal of molecular sciences, 2016)